Plasmodium Immunotherapy for Breast and Liver Cancers

NCT03474822 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

CAS Lamvac Biotech Co., Ltd.